ARO-TSLP

N/A

Report date: 2024/06/03 15:15:40
NME

Base Information

Drug NameARO-TSLP
Drug Alias NameARO-TSLP
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionThymic stromal lymphopoietin inhibitorsRNA interference
TargetsThymic stromal lymphopoietin
Therapy Area/IndicationsAllergic asthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesArrowhead Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesArrowhead Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsAllergic asthma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A